Corrigendum to "Evaluating change in diet with pegvaliase treatment in adults with phenylketonuria: Analysis of phase 3 clinical trial data" [Molecular Genetics and Metabolism 141, Issue 3 (2024) 108122]
Mol Genet Metab
.
2024 Dec;143(4):108613.
doi: 10.1016/j.ymgme.2024.108613.
Epub 2024 Nov 26.
Authors
Fran Rohr
1
,
Barbara Burton
2
,
Anne Dee
3
,
Cary O Harding
4
,
Joshua Lilienstein
3
,
Kristin Lindstrom
3
,
Erin MacLeod
5
,
Sarah Rose
3
,
Rani Singh
6
,
Sandra van Calcar
4
,
Kaleigh Whitehall
3
Affiliations
1
Met Ed, Boulder, CO, USA. Electronic address:
[email protected]
.
2
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
3
BioMarin Pharmaceutical Inc., Novato, CA, USA.
4
Oregon Health & Science University, Portland, OR, USA.
5
Children's National Rare Disease Institute, Washington, DC, USA.
6
Emory University, Atlanta, GA, USA.
PMID:
39591708
DOI:
10.1016/j.ymgme.2024.108613
No abstract available
Publication types
Published Erratum